Democratic Republic of Congo is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. The clearest coverage concentration is market-trends: 1 of 2 stories, with the rest divided among 1 other category. Each carries 3 original sources on average.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Red Cross
Democratic Republic of Congo is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. The clearest coverage concentration is market-trends: 1 of 2 stories, with the rest divided among 1 other category. Each carries 3 original sources on average. We currently track 2 Cross-Sector stories that mention Red Cross, all published on July 12, 2026.
Stories tracked
2
Sources per story
3
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Red Cross. Shared-story counts are live from our verified record — not editorial picks.
The Bundibugyo ebolavirus outbreak in Congo has no approved vaccine or treatment, creating a pressing unmet medical need. With 894 cases and over 200 deaths, the crisis could accelerate biopharma R&D for neglected filovirus strains.
Healthcare responders in eastern Congo face mounting challenges as the Bundibugyo Ebola outbreak reaches 894 confirmed cases and over 200 deaths. A third orphanage death underscores infection control failures in congregate settings and the need for community-sensitive interventions.